SCHEMBL20569065

SCHEMBL20569065

N=C1NCCN1Cc1ccncc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
CYP2D6 P10635 4/20 0.42
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 4/20 0.41
CYP2C19 P33261 3/20 0.41
CYP11B1 P15538 1/20 0.39
CYP2C9 P11712 2/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
CYP1A2 P05177 2/20 0.38
HSD17B10 Q99714 1/20 0.38
LSS P48449 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ADRB2 P07550 1/20 0.36
NCF1 P14598 1/20 0.36
PLD1 Q13393 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246385 0.83 SIGMAR1 (0.48) CYP2D6ALDH1A1POLBCYP3A4CYP2C19
Bromide SCHEMBL11669278 0.81 SIGMAR1 (0.47) CYP2D6ALDH1A1POLBCYP3A4CYP2C19
SCHEMBL24709610 0.81 ALDH1A1 (0.46) ALDH1A1POLBCYP2C19CYP11B1CYP2C9
SCHEMBL24709607 0.80 ALDH1A1 (0.67) CYP2D6ALDH1A1POLBCYP3A4CYP2C19
SCHEMBL24709613 0.80 SMN1; SMN2 (0.57) ALDH1A1POLBCYP11B1SMN1; SMN2
SCHEMBL24709604 0.80 ALDH1A1 (0.45) ALDH1A1POLBCYP2C19CYP11B1CYP2C9
Bromide SCHEMBL31141392 0.80 ALDH1A1 (0.45) ALDH1A1POLBCYP2C19CYP11B1CYP2C9
SCHEMBL7999499 0.80 CHRNB2 (0.54) ALDH1A1CYP11B1TDP1KDM4ESMN1; SMN2
SCHEMBL24709611 0.80 ALDH1A1 (0.50) ALDH1A1POLBCYP3A4L3MBTL1KDM4E
SCHEMBL9677155 0.79 POLB (0.66) HPGDCYP2D6ALDH1A1POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200179361-A1 COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT TORREY PINES INST FOR MOLECULAR STUDIES (US) 2020-06-11 US disclosed
WO-2018217631-A1 COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 2018-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200179361-A1 COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT CHRNA4, CHRNA5, CHRNB4 HPGD 1684/4885CYP2D6 2997/4885ALDH1A1 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.